Emami Acquires Full Stake in Axiom Ayurveda for Rs.200 Crores
Filing Summary
Emami Limited has signed a definitive agreement to acquire the remaining 73.5% stake in Axiom Ayurveda Pvt Ltd, known for its “AloFrut” brand, for a total consideration not exceeding Rs.200 crores. This acquisition, approved by Emami’s Board of Directors, marks the company’s entry into the beverage sector. The transaction is expected to close within three months, subject to customary conditions. Axiom’s portfolio includes beverages, health juices, and beauty products. The acquisition aligns with Emami’s strategy to expand into high-opportunity categories in the health and wellness space.
Emami Limited has executed a definitive agreement to acquire the remaining 73.5% stake in Axiom Ayurveda Pvt Ltd, which operates under the brand name “AloFrut”. This acquisition is subject to customary closing conditions and is expected to be completed within three months. The transaction marks Emami’s formal entry into the beverage sector.
The acquisition involves an aggregate consideration not exceeding Rs.200 crores. Emami initially acquired an additional 36.7% stake, adding to its existing 26.5% stake in Axiom. The transaction has received approval from Emami’s Board of Directors and will be executed in a phased manner in accordance with the terms of the agreement and applicable regulatory requirements.
Axiom Ayurveda Pvt Ltd’s portfolio includes beverage products under the brand “AloFrut”, health juices under “Axiom Jeevan Ras”, and beauty products under “Mukti Gold”. The company is known for its fusion of aloe vera pulp with fruit blends, offering a range of unique flavors. Axiom also produces mocktails, energy drinks, and ayurvedic juices. The company has a strong market presence across general trade and government institutions.
The acquisition aligns with Emami’s strategy to expand into emerging, high-opportunity categories that align with evolving consumer preferences, particularly in the health and wellness space. Emami has been in partnership with Axiom for over two and a half years, gaining valuable insights into the segment. Axiom is a profitable company, with an expected topline of around Rs.180 crore for FY26.
The transaction is expected to be completed within three months, subject to customary closing conditions. Emami has onboarded Mr. Harkirat Bedi as the Chief Executive Officer of Axiom Ayurveda Pvt Ltd. His appointment is anticipated to strengthen the leadership team and accelerate the company’s expansion in the health and wellness beverage segment.
Emami Limited, founded in 1974, is a leading FMCG company in India, engaged in the manufacturing and marketing of personal care and healthcare products. The company’s portfolio includes brands like Navratna, BoroPlus, Fair & Handsome, Zandu Balm, Mentho Plus, and Kesh King. Emami has expanded its business through strategic acquisitions, including Zandu Pharmaceuticals, Kesh King, Creme 21, and Dermicool. Emami products are available in over 5.4 million retail outlets across India and in more than 70 countries globally.